Daily non-political popular news in brief.
Active ingredient in common Chinese herb
01-18-2007 · EurekAlert!Some 50 million Americans have hypertension, that is, blood pressure measuring above the normal range (less than 120/80 mmHg). If untreated, it can lead to heart attacks, strokes, or kidney disease. Lifestyle changes are the first-stage treatment for the disease, but if they fail, medications are prescribed. In a soon-to-be-released study using an animal model, scientists have found that tanshinone IIA, an active ingredient of danshen, reduces blood pressure.
Read more »
Keywords: active, ingredient, chinese, herb
« Previous | Next »
Similar news on "Active ingredient in common Chinese herb":
- Active ingredient in common Chinese herb shown to reduce hypertension
01-18-2007 · EurekAlert!
Some 50 million Americans have hypertension, that is, blood pressure measuring above the normal range (less than 120/80 mmHg). If untreated, it can lead to heart attacks, strokes, or kidney disease. Lifestyle changes are the first-stage treatment for the disease, but if they fail, medications are prescribed. In a soon-to-be-released study using an animal model, scientists have found that tanshinone IIA, an active ingredient of danshen, reduces blood pressure.
Similar news · Read more »
- Rosemary chicken protects your brain from free radicals
10-30-2007 · EurekAlert!
A collaborative group from the Burnham Institute for Medical Research (Burnham Institute) in La Jolla, Calif., and in Japan, report that the herb rosemary contains an ingredient that fights off free radical damage in the brain. The active ingredient in rosemary, known as carnosic acid, can protect the brain from stroke and neurodegeneration that is due to injurious chemical free radicals.
Similar news · Read more »
- New study demonstrates that Lubiprostone may improve symptom relief rates in adults with IBS-C
05-21-2007 · EurekAlert!
A new study demonstrated that the active ingredient in AMITIZA (lubiprostone), given 8 mcg twice a day, may improve symptom relief rates in adults with irritable bowel syndrome with constipation (IBS-C). These results were presented as a late-breaker at Digestive Disease Week 2007, the largest annual international meeting of digestive disease specialists.
Similar news · Read more »
- Study: cannabis a double-edged sword
10-23-2007 · EurekAlert!
A new neurobiological study conducted by McGill University researchers has found that a synthetic form of THC, the active ingredient in cannabis, is an effective anti-depressant at low doses. However, at higher doses, the effect reverses itself and can actually worsen depression and other psychiatric conditions like psychosis.
Similar news · Read more »
- Scientists isolate chemical in curry that may help immune system clear plaques found in Alzheimer's
07-16-2007 · EurekAlert!
Researchers isolated bisdemethoxycurcumin, the active ingredient of curcuminoids -- a natural substance found in turmeric root -- that may help boost the immune system in clearing amyloid beta, a peptide that forms the plaques found in Alzheimer's disease.
Similar news · Read more »
- Chemical compound present in detergents produce bacteria alterations in agricultural soils
11-08-2007 · EurekAlert!
A research project conducted by the University of Granada followed the activity of farm grounds due to the increasing presence of linear alkyl benzene sulphonate, a chemical compound whose active ingredient can be found in most detergents. The high demand of water for farming, the use of distilled water and the use of biological mixtures cause the presence of this chemical component in soils.
Similar news · Read more »
- LIALDA demonstrates prolonged release of mesalamine in an in vitro study using a simulated colon
10-17-2007 · EurekAlert!
According to a study using a dynamic in vitro gastrointestinal tract system, Shire plc's ulcerative colitis drug LIALDA (mesalamine) demonstrated a delivery system where the majority of the drug's active ingredient, 5-aminosalicyclic acid, is released over a prolonged period in the simulated colon. The colon is the site of inflammation in ulcerative colitis.
Similar news · Read more »
- LIALDA demonstrates prolonged release of mesalamine
10-17-2007 · EurekAlert!
According to a study using a dynamic in vitro gastrointestinal tract system, Shire plc's ulcerative colitis drug LIALDA (mesalamine) demonstrated a delivery system where the majority of the drug's active ingredient, 5-aminosalicyclic acid, is released over a prolonged period in the simulated colon. The colon is the site of inflammation in ulcerative colitis.
Similar news · Read more »
- A new target for the treatment of breast cancer
01-11-2007 · EurekAlert!
The active ingredient in a drug currently being tested to treat rheumatoid arthritis might also one day serve as an effective means of treating one of the deadliest forms of breast cancer. Berkeley Lab researchers have demonstrated that inhibiting the activity of the protease enzyme known as TACE can deprive tumor cells of a key factor needed for their proliferation. TACE is strongly present in a form of breast cancer which responds poorly to current therapies.
Similar news · Read more »
- LIALDA (TM) demonstrates prolonged release of mesalamine
10-17-2007 · EurekAlert!
According to a study using a dynamic in vitro gastrointestinal tract system, Shire plc's ulcerative colitis drug LIALDA (mesalamine) demonstrated a delivery system where the majority of the drug's active ingredient, 5-aminosalicyclic acid, is released over a prolonged period in the simulated colon. The colon is the site of inflammation in ulcerative colitis.
Similar news · Read more »
